维替泊芬光动力疗法联合玻璃体腔内注射贝伐单抗治疗渗出性年龄相关性黄斑变性。 - Suppr

Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for exudative age-related macular degeneration.

作者信息

Aggio Fabio Bom, Melo Gustavo Barreto, Höfling-Lima Ana Luisa, Eid Farah Michel

出版信息

Acta Ophthalmol Scand. 2006 Dec;84(6):831-3. doi: 10.1111/j.1600-0420.2006.00764.x.

DOI:10.1111/j.1600-0420.2006.00764.x

PMID:17083553

Abstract

摘要

相似文献

Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for exudative age-related macular degeneration.

Acta Ophthalmol Scand. 2006 Dec;84(6):831-3. doi: 10.1111/j.1600-0420.2006.00764.x.

Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.

Retina. 2006 Nov-Dec;26(9):988-93. doi: 10.1097/01.iae.0000247164.70376.91.

Necessity of paracentesis before or after intravitreal injection of bevacizumab.

Arch Ophthalmol. 2008 Sep;126(9):1314-5; author reply 1315. doi: 10.1001/archopht.126.9.1314.

Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.

Ophthalmology. 2007 Jun;114(6):1179-85. doi: 10.1016/j.ophtha.2007.03.006.

Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone.

Retina. 2007 Feb;27(2):133-40. doi: 10.1097/IAE.0b013e3180323de7.

Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration.

Arch Ophthalmol. 2007 Oct;125(10):1357-61. doi: 10.1001/archopht.125.10.1357.

Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1273-80. doi: 10.1007/s00417-007-0557-x. Epub 2007 Feb 28.

Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.

Ophthalmology. 2009 Apr;116(4):747-55, 755.e1. doi: 10.1016/j.ophtha.2008.12.057. Epub 2009 Feb 25.

Same-day triple therapy with photodynamic therapy, intravitreal dexamethasone, and bevacizumab in wet age-related macular degeneration.

Retina. 2009 May;29(5):573-8. doi: 10.1097/IAE.0b013e3181a46a8a.

Combined intravitreal bevacizumab and photodynamic therapy for neovascular age-related macular degeneration.

Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):17-25. doi: 10.1007/s00417-007-0654-x. Epub 2007 Aug 15.

引用本文的文献

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration.

Cochrane Database Syst Rev. 2008 Apr 16(2):CD005139. doi: 10.1002/14651858.CD005139.pub2.

Bevacizumab: off-label use in ophthalmology.

Indian J Ophthalmol. 2007 Nov-Dec;55(6):417-20. doi: 10.4103/0301-4738.36474.

Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.

BMC Ophthalmol. 2007 Jun 7;7:10. doi: 10.1186/1471-2415-7-10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for exudative age-related macular degeneration.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献